Apixaban vs warfarin was associated with less ischemic stroke and major bleeding among patients with atrial fibrillation and stage 4-5 CKD not on dialysis.
https://www.renalandurologynews.com/news/chronic-kidney-disease-ckd-apixaban-warfarin-appears-less-afib-treatment/
https://www.renalandurologynews.com/news/chronic-kidney-disease-ckd-apixaban-warfarin-appears-less-afib-treatment/
Apixaban vs Warfarin Appears Less Risky for Advanced CKD With AFib
A target trial emulation compared stroke and bleeding risks after apixaban vs warfarin in stage 4-5 chronic kidney disease with atrial fibrillation.
www.renalandurologynews.com
September 28, 2026 at 7:35 PM
Apixaban vs warfarin was associated with less ischemic stroke and major bleeding among patients with atrial fibrillation and stage 4-5 CKD not on dialysis.
https://www.renalandurologynews.com/news/chronic-kidney-disease-ckd-apixaban-warfarin-appears-less-afib-treatment/
https://www.renalandurologynews.com/news/chronic-kidney-disease-ckd-apixaban-warfarin-appears-less-afib-treatment/
I appreciate your work helping provide reasonable prices for drugs - I buy Exemestane from your company! Because of Big Pharma, I still have to buy Apixaban from a Canadian pharmacy (it's not available in the US). Even with Trump's tariffs added it's STILL cheaper buying from our Canadian friends!
September 28, 2026 at 4:09 PM
I appreciate your work helping provide reasonable prices for drugs - I buy Exemestane from your company! Because of Big Pharma, I still have to buy Apixaban from a Canadian pharmacy (it's not available in the US). Even with Trump's tariffs added it's STILL cheaper buying from our Canadian friends!
Lupin Limited Secures Tentative FDA Approval for Apixaban Oral Suspension to Enhance Patient Treatment Options#FDA_Approval#Lupin_Limited#Apixaban_Oral_Suspension
Lupin Limited Secures Tentative FDA Approval for Apixaban Oral Suspension to Enhance Patient Treatment Options
Lupin Limited has announced tentative FDA approval for Apixaban Oral Suspension, providing a new administration option for patients requiring anticoagulation therapy.
third-news.com
September 28, 2026 at 1:31 PM
Lupin Limited Secures Tentative FDA Approval for Apixaban Oral Suspension to Enhance Patient Treatment Options#FDA_Approval#Lupin_Limited#Apixaban_Oral_Suspension
The product is a novel oral liquid formulation of apixaban (the active ingredient in Eliquis®), offering an alternative administration opt...
🚀 Free alerts → https://gunpowderalerts.in/go?utm_source=bluesky&utm_medium=social&utm_campaign=high_priority_filing
#FinTwit #Healthcare #TradingSuspension
🚀 Free alerts → https://gunpowderalerts.in/go?utm_source=bluesky&utm_medium=social&utm_campaign=high_priority_filing
#FinTwit #Healthcare #TradingSuspension
September 28, 2026 at 4:31 AM
The product is a novel oral liquid formulation of apixaban (the active ingredient in Eliquis®), offering an alternative administration opt...
🚀 Free alerts → https://gunpowderalerts.in/go?utm_source=bluesky&utm_medium=social&utm_campaign=high_priority_filing
#FinTwit #Healthcare #TradingSuspension
🚀 Free alerts → https://gunpowderalerts.in/go?utm_source=bluesky&utm_medium=social&utm_campaign=high_priority_filing
#FinTwit #Healthcare #TradingSuspension
Lupin Limited — Trading Suspension
Lupin Limited announced it has received tentative approval from the U.S. FDA for its New Drug Application for Apixaban Oral Suspension 1.25 mg/mL via the 505(b)(2) pathway.
🧵 continued ↓
Lupin Limited announced it has received tentative approval from the U.S. FDA for its New Drug Application for Apixaban Oral Suspension 1.25 mg/mL via the 505(b)(2) pathway.
🧵 continued ↓
September 28, 2026 at 4:31 AM
Lupin Limited — Trading Suspension
Lupin Limited announced it has received tentative approval from the U.S. FDA for its New Drug Application for Apixaban Oral Suspension 1.25 mg/mL via the 505(b)(2) pathway.
🧵 continued ↓
Lupin Limited announced it has received tentative approval from the U.S. FDA for its New Drug Application for Apixaban Oral Suspension 1.25 mg/mL via the 505(b)(2) pathway.
🧵 continued ↓
But because Eliquis is available in the US, it seems my shipments of Apixaban will be stopped after Oct 22. The Canadian company is helping me get all my refills before then, but after that I don't know what I will do.
September 23, 2026 at 1:25 PM
But because Eliquis is available in the US, it seems my shipments of Apixaban will be stopped after Oct 22. The Canadian company is helping me get all my refills before then, but after that I don't know what I will do.
I deal with a Canadian company to get Apixaban, the generic form of Eliquis, a blood thinner that helps prevent strokes. I pay about $24 a month for this generic, which is not available in the US. The price quoted to me for Eliquis was $389/mo, which I cannot afford.
September 23, 2026 at 1:25 PM
I deal with a Canadian company to get Apixaban, the generic form of Eliquis, a blood thinner that helps prevent strokes. I pay about $24 a month for this generic, which is not available in the US. The price quoted to me for Eliquis was $389/mo, which I cannot afford.
These findings suggest that among patients with atrial fibrillation and advanced chronic kidney disease not receiving dialysis, apixaban may be the preferred oral anticoagulant when anticoagulation is considered.
September 22, 2026 at 8:34 PM
These findings suggest that among patients with atrial fibrillation and advanced chronic kidney disease not receiving dialysis, apixaban may be the preferred oral anticoagulant when anticoagulation is considered.
Oral Anticoagulants in Patients With AF and Advanced CKD Not Requiring Dialysis jamanetwork.com/journals/jam...
Oral Anticoagulants in Patients With AF and Advanced CKD Not Requiring Dialysis
This cohort study compares bleeding and stroke associated with apixaban, warfarin, and no oral anticoagulant use among patients with atrial fibrillation (AF) and chronic kidney disease (CKD) not requi...
jamanetwork.com
September 22, 2026 at 8:34 PM
Oral Anticoagulants in Patients With AF and Advanced CKD Not Requiring Dialysis jamanetwork.com/journals/jam...
Newer blood thinners can do more than just prevent strokes & atrial fibrillation. Researchers found that patients taking NOACs (Eliquis [apixaban], rivaroxaban, edoxaban, dabigatran) experienced a slower decline in cognitive function
www.sciencedaily.com/releases/202...
www.sciencedaily.com/releases/202...
These blood thinners may have an unexpected benefit for Alzheimer’s patients
Newer blood thinners may do more than prevent strokes in people with Alzheimer’s disease and atrial fibrillation. Researchers found that patients taking NOACs experienced a slower decline in cognitive...
www.sciencedaily.com
September 22, 2026 at 12:21 AM
Newer blood thinners can do more than just prevent strokes & atrial fibrillation. Researchers found that patients taking NOACs (Eliquis [apixaban], rivaroxaban, edoxaban, dabigatran) experienced a slower decline in cognitive function
www.sciencedaily.com/releases/202...
www.sciencedaily.com/releases/202...
In advanced non-dialysis CKD + AF, apixaban was linked to ↓ ischemic stroke but ↑ major bleeding vs no anticoagulation. Warfarin ↑ bleeding without significant stroke reduction. Apixaban showed a more favorable benefit–risk balance vs warfarin. #CKD
🔗 jamanetwork.com/journals/jam...
🔗 jamanetwork.com/journals/jam...
Oral Anticoagulants in Patients With AF and Advanced CKD Not Requiring Dialysis
This cohort study compares bleeding and stroke associated with apixaban, warfarin, and no oral anticoagulant use among patients with atrial fibrillation (AF) and chronic kidney disease (CKD) not…
jamanetwork.com
September 18, 2026 at 9:13 PM
In advanced non-dialysis CKD + AF, apixaban was linked to ↓ ischemic stroke but ↑ major bleeding vs no anticoagulation. Warfarin ↑ bleeding without significant stroke reduction. Apixaban showed a more favorable benefit–risk balance vs warfarin. #CKD
🔗 jamanetwork.com/journals/jam...
🔗 jamanetwork.com/journals/jam...
"He Takes Eliquis for an Irregular Heartbeat. At 71, That One Prescription Can Be Enough for a Medigap Insurer to Say No" (#AFib) (24/7 Wall Street) on SmartNews: l.smartnews.com/p-8wgF5Rrq/J... #SmartNews
He Takes Eliquis for an Irregular Heartbeat. At 71, That One Prescription Can Be Enough for a Medigap Insurer to Say No (24/7 Wall St.)
He's 71, otherwise healthy, and takes apixaban twice a day. Sold as Eliquis, it keeps atrial fibrillation from throwing a clot, and it's the only...
l.smartnews.com
September 18, 2026 at 2:23 PM
"He Takes Eliquis for an Irregular Heartbeat. At 71, That One Prescription Can Be Enough for a Medigap Insurer to Say No" (#AFib) (24/7 Wall Street) on SmartNews: l.smartnews.com/p-8wgF5Rrq/J... #SmartNews
Taking apixaban for atrial fibrillation can cause Medigap insurers to deny coverage or underwrite more strictly outside the guaranteed enrollment window.
Save What Matters
Curate Feeds | Make Collections | Customize Email Briefs
briefly.co
September 18, 2026 at 11:33 AM
Taking apixaban for atrial fibrillation can cause Medigap insurers to deny coverage or underwrite more strictly outside the guaranteed enrollment window.
Taking apixaban for atrial fibrillation can cause Medigap insurers to deny coverage or underwrite more strictly outside the guaranteed enrollment window.
Save What Matters
Curate Feeds | Make Collections | Customize Email Briefs
briefly.co
September 18, 2026 at 11:33 AM
Taking apixaban for atrial fibrillation can cause Medigap insurers to deny coverage or underwrite more strictly outside the guaranteed enrollment window.
Taking apixaban for atrial fibrillation can cause Medigap insurers to deny coverage or underwrite more strictly outside the guaranteed enrollment window.
Save What Matters
Curate Feeds | Make Collections | Customize Email Briefs
briefly.co
September 18, 2026 at 11:32 AM
Taking apixaban for atrial fibrillation can cause Medigap insurers to deny coverage or underwrite more strictly outside the guaranteed enrollment window.
Massive congratulations Mark... ~8 million in US on blood thinner/anti coagulants, with close to ~6 million on orals like apixaban (Eliquis) or rivaroxaban (Xarelto). These and warfarin (~2 million) are CRAZY expensive and sending many families into bankruptcy. Congrats!
September 17, 2026 at 8:56 PM
Massive congratulations Mark... ~8 million in US on blood thinner/anti coagulants, with close to ~6 million on orals like apixaban (Eliquis) or rivaroxaban (Xarelto). These and warfarin (~2 million) are CRAZY expensive and sending many families into bankruptcy. Congrats!
How should renal function influence anticoagulant choice? Thomas Mavrakanas tackles Apixaban in CKD and ESRD at this year’s Rapid Fire session.
Nov. 7 | Montréal
thrombosiscanada.ca/2026Conference
#Thrombosis #Anticoagulation
Nov. 7 | Montréal
thrombosiscanada.ca/2026Conference
#Thrombosis #Anticoagulation
September 17, 2026 at 12:30 PM
How should renal function influence anticoagulant choice? Thomas Mavrakanas tackles Apixaban in CKD and ESRD at this year’s Rapid Fire session.
Nov. 7 | Montréal
thrombosiscanada.ca/2026Conference
#Thrombosis #Anticoagulation
Nov. 7 | Montréal
thrombosiscanada.ca/2026Conference
#Thrombosis #Anticoagulation
Elderly woman on blood thinner here, specifically apixaban. Bruising is not unusual, and in my experience appears mild. I do believe he meets the DSM criteria for narcissistic personality disorder and antisocial personality disorder. Maybe that's something reporters should be investigating?
September 17, 2026 at 3:46 AM
Elderly woman on blood thinner here, specifically apixaban. Bruising is not unusual, and in my experience appears mild. I do believe he meets the DSM criteria for narcissistic personality disorder and antisocial personality disorder. Maybe that's something reporters should be investigating?
Here are 5 essential anticoagulants every healthcare professional should know:
1. Aspirin
2. Warfarin
3. Clopidogrel
4. Rivaroxaban
5. Apixaban
Boost your clinical knowledge today
Read here: fadic.net/the-most-com... ✅
#Pharmacy #Anticoagulants #Pharmacology #BloodThinners
#FADIC #ClinicalPharmacy
1. Aspirin
2. Warfarin
3. Clopidogrel
4. Rivaroxaban
5. Apixaban
Boost your clinical knowledge today
Read here: fadic.net/the-most-com... ✅
#Pharmacy #Anticoagulants #Pharmacology #BloodThinners
#FADIC #ClinicalPharmacy
The Most Common Anticoagulant Drugs
Discover the uses and dosing of anticoagulant drugs, including aspirin. Learn how these medications can help prevent serious cardiovascular events.
fadic.net
September 14, 2026 at 2:02 AM
Here are 5 essential anticoagulants every healthcare professional should know:
1. Aspirin
2. Warfarin
3. Clopidogrel
4. Rivaroxaban
5. Apixaban
Boost your clinical knowledge today
Read here: fadic.net/the-most-com... ✅
#Pharmacy #Anticoagulants #Pharmacology #BloodThinners
#FADIC #ClinicalPharmacy
1. Aspirin
2. Warfarin
3. Clopidogrel
4. Rivaroxaban
5. Apixaban
Boost your clinical knowledge today
Read here: fadic.net/the-most-com... ✅
#Pharmacy #Anticoagulants #Pharmacology #BloodThinners
#FADIC #ClinicalPharmacy
Apixaban (Eliquis) is associated with reduced rates of ischemic stroke and bleeding in ... - goo.gl/alerts/tZtNpK #GoogleAlerts
Apixaban (Eliquis) is associated with reduced rates of ischemic stroke and bleeding in patients with atrial fibrillation and advanced chronic kidney disease compared with warfarin (Coumadin) | 2 Minut...
1. In patients with atrial fibrillation and advanced chronic kidney disease (CKD) not receiving dialysis, apixaban (Eliquis) was associated with significantly lower rates of bleeding and ischemic stro...
goo.gl
September 11, 2026 at 10:29 AM
Apixaban (Eliquis) is associated with reduced rates of ischemic stroke and bleeding in ... - goo.gl/alerts/tZtNpK #GoogleAlerts
Andexanet (Andexxa), aprobado para revertir hemorragias graves asociadas a apixabán y rivaroxabán, será retirado del mercado estadounidense.
El ensayo ANNEXA-I encontró más eventos tromboembólicos con andexanet que con la atención habitual.
www.saludyfarmacos.org/boletin-farm...
El ensayo ANNEXA-I encontró más eventos tromboembólicos con andexanet que con la atención habitual.
www.saludyfarmacos.org/boletin-farm...
September 8, 2026 at 12:39 AM
Andexanet (Andexxa), aprobado para revertir hemorragias graves asociadas a apixabán y rivaroxabán, será retirado del mercado estadounidense.
El ensayo ANNEXA-I encontró más eventos tromboembólicos con andexanet que con la atención habitual.
www.saludyfarmacos.org/boletin-farm...
El ensayo ANNEXA-I encontró más eventos tromboembólicos con andexanet que con la atención habitual.
www.saludyfarmacos.org/boletin-farm...
This is the kind of question that either needs a randomised trial or a clever instrumental variable, propensity score is no better than simple adjustment. Confounding by indication and other unmeasured confounding is too strong. #nephsky #cardiosky jamanetwork.com/journals/jam...
Oral Anticoagulants in Patients With AF and Advanced CKD Not Requiring Dialysis
This cohort study compares bleeding and stroke associated with apixaban, warfarin, and no oral anticoagulant use among patients with atrial fibrillation (AF) and chronic kidney disease (CKD) not requi...
jamanetwork.com
September 7, 2026 at 7:04 PM
This is the kind of question that either needs a randomised trial or a clever instrumental variable, propensity score is no better than simple adjustment. Confounding by indication and other unmeasured confounding is too strong. #nephsky #cardiosky jamanetwork.com/journals/jam...
Among patients with #AtrialFibrillation and advanced #ChronicKidneyDisease not receiving dialysis, apixaban was associated with lower ischemic stroke risk and higher bleeding risk vs no anticoagulation, but lower bleeding and stroke risk vs warfarin.
ja.ma/4ibaM5n
ja.ma/4ibaM5n
September 6, 2026 at 3:00 PM
Among patients with #AtrialFibrillation and advanced #ChronicKidneyDisease not receiving dialysis, apixaban was associated with lower ischemic stroke risk and higher bleeding risk vs no anticoagulation, but lower bleeding and stroke risk vs warfarin.
ja.ma/4ibaM5n
ja.ma/4ibaM5n
It's the #JGIM Bottom Line: 12 Months of Low-dose Apixaban Decreased #VTE Recurrence After 3 Months of Initial Treatment of a Triggered Venous Thromboembolism with Continuing Risk Factors
Read it all: rdcu.be/fmNpQ
Read it all: rdcu.be/fmNpQ
September 2, 2026 at 9:02 PM
It's the #JGIM Bottom Line: 12 Months of Low-dose Apixaban Decreased #VTE Recurrence After 3 Months of Initial Treatment of a Triggered Venous Thromboembolism with Continuing Risk Factors
Read it all: rdcu.be/fmNpQ
Read it all: rdcu.be/fmNpQ
🔬 Anticoagulation in atrial fibrillation with CKD demands a careful balance between thromboembolic prevention and bleeding risk. @kidney.org
#AtrialFibrillation #CKD
🔗 www.xiahepublishing.com/2590-3438/JT...
#AtrialFibrillation #CKD
🔗 www.xiahepublishing.com/2590-3438/JT...
Anticoagulant Strategies in Atrial Fibrillation and Chronic Kidney Disease: From Pathophysiology to Clinical Practice
Atrial fibrillation and chronic kidney disease (CKD) frequently coexist, increasing thromboembolic and bleeding risks. This is a narrative review of pathophysiology and clinical evidence for anticoagulation strategies in CKD patients. Direct oral anticoagulants are preferred in CKD stages 1–4. Recent data suggest that the efficacy of apixaban and rivaroxaban is comparable to that of warfarin in end-stage renal disease. In advanced CKD, anticoagulation should be tailored with close monitoring.
www.xiahepublishing.com
September 2, 2026 at 5:30 PM
🔬 Anticoagulation in atrial fibrillation with CKD demands a careful balance between thromboembolic prevention and bleeding risk. @kidney.org
#AtrialFibrillation #CKD
🔗 www.xiahepublishing.com/2590-3438/JT...
#AtrialFibrillation #CKD
🔗 www.xiahepublishing.com/2590-3438/JT...